ArticleCureus2025
Neurological Complications of Type 2 Diabetes Mellitus: A Duration-Based Comparative Study at a Secondary Care Hospital in Karachi, Pakistan.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Type 2 diabetes mellitus (T2DM) often leads to neurological complications that tend to increase in severity with disease duration. This study compared the prevalence of neurological symptoms in individuals with T2DM with respect to the duration of disease. Methodology This cross-sectional study was carried out over a six-month period at secondary care hospitals. A total of 420 patients with T2DM, aged between 40 and 65 years, were categorized into three equal groups of 140 based on duration of diabetes. Group A included newly diagnosed patients (less than or equal to one year), Group B comprised individuals with one to five years of diabetes, and Group C consisted of those with a duration exceeding five years. Clinical evaluations focused on glycemic control (glycated hemoglobin (HbA1c) and postprandial glucose) and neurological complications involving peripheral, autonomic, and central nervous systems. Data were analyzed using IBM SPSS Statistics for Windows, Version 20 (Released 2012; IBM Corp., Armonk, New York, United States), with chi-square and Mann-Whitney tests applied, with p-values <0.05 taken as statistically significant. Results This study's findings showed that Group A (less than or equal to one year) had significantly higher mean age, weight, BMI, respiratory rate, heart rate, and random blood sugar levels compared to Groups B and C. Gender distribution varied significantly, with all males in Group A and more females in Group B. Dyslipidemia and smoking history were significantly associated with diabetes duration (p < 0.001), while hypertension was not. Neuropathy symptoms, especially tingling and numbness, were more common in Group C, while autonomic symptoms like fatigue and irritability were highest in Group B. Socioeconomic status and type of therapy also showed significant differences across groups (p < 0.05). Conclusion This study concluded that peripheral neuropathy symptoms were more common in patients with longer diabetes duration, indicating progressive nerve damage over time. Some symptoms, such as burning pain and fatigue, appeared earlier, suggesting early metabolic changes. Autonomic symptoms also varied significantly, highlighting the complex progression of neurological involvement in T2DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.